Gordon LB et al., 2018-04-24: Observational cohort study matching 63 lonafarnib-treated children with progeria to 63 untreated matched patients, finding markedly lower mortality with lonafarnib; the authors caution the design is observational.
Treatment was associated with a lower mortality rate (hazard ratio, 0.12; 95% CI, 0.01-0.93; P = .04). In the combined cohort, there were 4 deaths (6.3%) among 63 patients in the treated group
abstract (vol 319, pp 1687-1695)
Gordon LB et al., 2018-04-24: Observational cohort study matching 63 lonafarnib-treated children with progeria to 63 untreated matched patients, finding markedly lower mortality with lonafarnib; the authors caution the design is observational. Study type: controlled study.
